Northrop Grumman delivered a strong finish to 2025, with Q4 sales of $11.7 billion (up 10% year-over-year) and full-year sales of $42 billion, exceeding the high end of guidance. The company generated $3.3 billion in free cash flow for the year, a 26% increase, driven by operational excellence and a record backlog exceeding $95 billion. Key performance drivers included growth in Aeronautics (B-21, F-35), Defense Systems (solid rocket motors, missile defense), and a return to growth in the Space segment. Management expressed high confidence entering 2026, guiding for sales of $43.5–44.0 billion and EPS of $27.40–27.90, supported by robust demand in strategic deterrence, munitions, and international markets (up 20% in 2025). Strategic highlights include the unveiling of the Project Talon uncrewed aircraft and significant capacity expansions in solid rocket motor production to meet surging demand.
| Metric | Value | Change |
|---|---|---|
| Q4 Sales | $11.7 billion | +10% YoY |
| FY 2025 Sales | $42.0 billion | +3% Organic |
| Q4 EPS (Adj) | $7.23 | +13% YoY |
| FY 2025 Free Cash Flow | $3.3 billion | +26% YoY |
| Backlog | $95 billion+ | Record High |
| 2026 Sales Guidance | $43.5 - $44.0 billion | Mid-single digit growth |
| 2026 EPS Guidance | $27.40 - $27.90 | Mid-single digit growth |
Management emphasized a strategic transformation focused on speed and affordability, moving beyond traditional 'exquisite' capabilities to scalable solutions. This is exemplified by Project Talon (YFQ-48A), an uncrewed aircraft designed and built in under 24 months, and a partnership with Kratos for the Valkyrie platform. This shift aligns with the Department of Defense's acquisition reform priorities, positioning Northrop to win high-volume contracts like the Collaborative Combat Aircraft (CCA) program.
Northrop is aggressively expanding its industrial capacity to address critical shortages in munitions, a top priority for the U.S. government. The company has doubled tactical solid rocket motor capacity at its ABL facility and plans to triple it by early 2027, with similar expansions planned for Elkton, MD by 2030. This proactive investment secures Northrop's position as a critical supplier in a expanding weapons market, supporting long-term revenue growth.
Strategic deterrence remains a core growth engine, comprising over 30% of the business. The B-21 program achieved key milestones, including the first flight of the second aircraft and the LRIP Lot 3 award, with negotiations ongoing for an accelerated production rate. Additionally, the Sentinel program continues to advance despite restructuring. These 'restricted' programs provide high barriers to entry and stable, long-term revenue visibility.
International growth is accelerating, with sales up 20% in 2025, driven by high demand for air and missile defense systems (IBCS), munitions, and radars. Management noted formal requests for IBCS from over 20 countries and expects significant awards in 2026 that will drive sales growth in 2027 and beyond. This diversification reduces reliance on U.S. budget cycles and leverages global geopolitical tensions.
The Sentinel program continues to face significant challenges and restructuring following the Nunn-McCurdy breach. Management is working with the Air Force to restructure the program and accelerate timelines, but the path to production remains uncertain. Kathy Warden noted that production will not begin until 'later in the decade,' creating a potential gap in revenue expectations and margin profile for this major strategic asset.
Aeronautics segment margins are expected to contract to the 'low to mid-nine percent' range in 2026, down from recent levels. CFO Ken Crews attributed this to the mix of development programs like B-21 and Takimo, noting the B-21 LRIP has a '0% margin profile.' This margin compression could weigh on overall profitability in the near term as these high-value programs ramp up.
Management signaled a pause in share repurchases beyond January 2026 to prioritize capital expenditures (CapEx) and debt reduction. CapEx is projected to rise to $1.65 billion (approx. 4% of sales) to fund capacity expansions. While this is a strategic investment, it signals a shift away from immediate shareholder returns via buybacks, which may disappoint income-focused investors.
The 2026 guidance for sales growth (mid-single digits) was viewed by analysts as conservative given the record $95 billion backlog. Management acknowledged the conservatism, citing the difficulty in predicting the timing of contract awards for B-21 acceleration and the FAXX program. This disconnect between backlog visibility and revenue guidance suggests potential execution risks or timing shifts that could impact near-term stock performance.
Overall: Management conveyed a highly confident and optimistic tone throughout the call, emphasizing the company's alignment with a 'robust demand environment' and 'historic growth' in defense spending. Kathy Warden was assertive regarding the company's strategic positioning and ability to deliver 'capabilities at a faster pace,' while the financial executives maintained a disciplined and steady demeanor during the transition between CFOs.
Confidence: HIGH - Management consistently exceeded guidance metrics (sales, EPS, FCF) and spoke with conviction about future growth, using definitive language like 'clear path,' 'unmatched,' and 'tremendous growth opportunity.' They provided specific details on capacity expansions and program milestones, reinforcing their outlook despite acknowledging the dynamic nature of contract timing.
$43.5 billion to $44.0 billion (mid-single digit growth)
$27.40 to $27.90 (mid-single digit growth)
Low-to-mid 11%
$3.1 billion to $3.5 billion
~$1.65 billion (approx 4% of sales)
Hedging & Uncertainty: Management employed moderate hedging, primarily regarding the timing of future contracts and government budget approvals. Phrases like 'optimistic that we will come to an agreement' and 'difficult to put our finger on' regarding B-21 acceleration timing suggest some uncertainty in the near-term execution of major deals. However, they balanced this with strong assertions about the demand environment, using 'clear path' and 'unmatched' to describe their positioning. The use of 'balanced approach' to describe guidance serves as a linguistic hedge against the unpredictability of the legislative acquisition process.
We are moving with urgency and proactive bringing innovative solutions to our customers. - Kathy Warden, Chair, CEO and President
This is the most robust demand environment I've seen in my career. - Kathy Warden, Chair, CEO and President
The plan at this point is is not to execute on additional buybacks beyond the end of of of this month, January. - John Green, CFO
We are purposely built and shaped our portfolio with a focus on our customers' demand signal. - Kathy Warden, Chair, CEO and President
We are encouraged by the recent 1 and a half trillion dollar FY twenty seven budget recommendation which indicates the potential for historic growth in defense spending. - Kathy Warden, Chair, CEO and President
Analyst Sentiment: Analysts were highly engaged, probing the perceived conservatism of 2026 guidance relative to the record backlog and inquiring about the mechanics of the B-21 acceleration. There was significant interest in the capital allocation strategy, specifically the pause in buybacks in favor of CapEx.
Management Responses: Management was transparent but firm on their 'balanced approach' to guidance, explaining that they excluded upside from B-21 acceleration and FAXX due to uncertain contract timing. They provided detailed rationale for the shift to CapEx, framing it as a necessary investment to capture 'historic' demand opportunities.
Discussion on the transformation of Northrop Grumman to prioritize speed and affordability, including the development of Project Talon.
Analysis of the $1.5 trillion FY27 budget recommendation and its implications for growth acceleration.
Clarification of the B-21 production rate acceleration, including the required $2-3 billion investment and expected EBIT impact.
Detailed breakdown of Aeronautics margin headwinds driven by development program mix (B-21, Takimo).
Updates on the Sentinel program restructuring and the expected timeline for production ramp.
International growth opportunities, specifically regarding IBCS and airborne radar awards.
Northrop Grumman is operating at a high level, executing on its strategy of technology leadership while successfully pivoting to meet customer demands for speed and scalability. The record backlog of $95 billion+ and 20% international growth demonstrate the strength of the portfolio, particularly in strategic deterrence and munitions. While 2026 guidance appears conservative and Aeronautics margins face near-term pressure, the long-term trajectory is robust. The decision to reinvest cash into capacity expansion (SRMs) rather than buybacks is prudent given the 'historic' demand environment, positioning the company for sustained revenue and earnings growth into 2027 and beyond. Risks regarding Sentinel delays are acknowledged but appear manageable within the diversified portfolio.
Management highlighted a '1 and a half trillion dollar FY twenty seven budget recommendation,' indicating potential for historic growth in defense spending. They noted strong bipartisan support and reconciliation investments focused on expanding manufacturing and capacity.
International demand is surging as allied nations enhance security capabilities. Northrop reported 20% international sales growth in 2025 and sees continued momentum in 2026, driven by demand for air defense, munitions, and radar systems.
Supply chain remains a pacing item, but Northrop is managing it through direct partnerships and government engagement. The company is investing in its own industrial base (e.g., tripling SRM capacity) to mitigate bottlenecks and support rapid delivery.